Page 15 - Mass General Brigham - Innovators Guide 1.2

15 INNO V AT O RS GUIDE | M ASS GENERAL BRIGH AM

2
About the

2 Innovation team

Within the Mass General Brigham organization, responsibility for • Identifying value-adding internal collaborators and intellectual property
commercialization of Mass General Brigham discoveries and technology- • Investing and access to translational capital
based innovation rests exclusively with Innovation. A business
development office, it serves all the hospitals within the system. Its large • Managing patent prosecution and other asset development
team includes PhDs, MDs, MBAs, and JDs and is dedicated to working • Negotiating deals with sponsors, collaborators, licensees and investors
collaboratively with Mass General Brigham employees to rapidly translate • Outlining proof of concept approaches
research outcomes into patient-benefiting products and services.
• Working collaboratively in a complex commercial environment
Innovation serves the system’s research and clinical community to make
the journey from concept to commercial outcome as efficient as possible. The Innovation office is organized into functional units that reflect
Its priorities include increasing the volume and value of Mass General each of the key elements in the commercialization process – industry
Brigham technologies, expanding the size of the innovation community collaboration, innovation management, licensing, strategy, investing,
system-wide, and accelerating commercial outcomes. company creation, translational research support, digital transformation,
financial distribution and compliance. The following describes the role of
Accelerating translational outcomes is an urgent system priority. the key units.
Innovation supports this mission in many ways:
• Accessing domain experts in areas such as regulatory Licensing
and reimbursement
• Assessing and managing intellectual property potential The Licensing team has expertise in science and technology, intellectual
property creation and management, deal-making and related compliance
• Coalescing system assets and industry issues. As described elsewhere in the guide, Licensing Managers evaluate
collaboration new inventions, market technologies, negotiate sponsored research
• Company creation and governance Accelerating agreements and option/license agreements, support the maintenance of IP
• Connecting technologies to market needs translational portfolios, and maintain relationships with licensees. The licensing team is
assigned by chief code to all clinical and research departments.
• Driving commercialization strategy outcomes
• Enabling translational research is an urgent For more information, please contact:
• Expanding use of advanced digital system priority. Rebecca Listfield PhD, rlistfield@partners.org
technologies